Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice

Leah Rogers1, Sarah Burchat, Jessica Gage

  • 1Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada.

Cardiovascular Research
|January 15, 2008
PubMed
Abstract

Insights

Selective depletion of V alpha 14 natural killer T (NKT) cells significantly reduced atherosclerosis progression in mice. This specific NKT cell population appears to promote the disease by increasing interferon-gamma expression.

Area of Science:

  • Immunology
  • Cardiovascular Research

Background:

  • Natural killer T (NKT) cells regulate immune responses.
  • Previous studies showed depleting all NKT cells reduces atherosclerosis.
  • The role of specific NKT cell subsets in atherosclerosis was unclear.

Purpose of the Study:

  • To determine if removing the V alpha 14 NKT cell population protects against atherosclerosis.
  • To investigate the specific contribution of V alpha 14 NKT cells to disease progression.

Main Methods:

  • Used J alpha 18 gene deletion to selectively deplete V alpha 14 NKT cells in LDL receptor null mice.
  • Fed mice a cholesterol- and fat-enriched diet for 8 weeks.
  • Quantified atherosclerosis lesion size and analyzed cytokine expression in lesions.

Main Results:

  • V alpha 14 NKT cell deficiency significantly reduced lesion size in the aortic root and arch.
  • No significant differences in serum cholesterol levels were observed between groups.
  • Reduced expression of the proatherogenic cytokine interferon-gamma (IFN-gamma) was found in lesions of deficient mice.

Conclusions:

  • Identified V alpha 14 NKT cells as a specific subpopulation promoting atherosclerosis.
  • The mechanism appears to involve the upregulation of IFN-gamma.
  • This finding offers a potential target for atherosclerosis treatment.